Xiaohui Xie Selected Research

Xiaohui Xie Research Topics

Disease

5	Neoplasms (Cancer) 05/2022 - 03/2016
3	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 01/2019
3	Neoplasm Metastasis (Metastasis) 12/2021 - 03/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2022 - 01/2020
2	Ovarian Epithelial Carcinoma 12/2021 - 12/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 04/2021
2	Breast Neoplasms (Breast Cancer) 02/2021 - 01/2021
2	Hemorrhage 04/2020 - 01/2019
2	Inflammation (Inflammations) 02/2020 - 12/2017
2	Carcinoma (Carcinomatosis) 01/2019 - 03/2016
1	Hepatocellular Carcinoma (Hepatoma) 06/2022
1	Hypothyroidism 06/2022
1	Hypercholesterolemia 01/2022
1	Hypertriglyceridemia 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2021
1	Melanoma (Melanoma, Malignant) 02/2021
1	Body Weight (Weight, Body) 01/2021
1	Heart Failure 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Anemia 01/2021
1	Tinnitus 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Cardiotoxicity 01/2021
1	Glucosephosphate Dehydrogenase Deficiency 10/2020
1	Acute Promyelocytic Leukemia 04/2020
1	Disseminated Intravascular Coagulation 04/2020
1	Thrombosis (Thrombus) 04/2020
1	COVID-19 01/2020
1	Airway Remodeling 01/2020
1	Emphysema 09/2019
1	Interdigitating Dendritic Cell Sarcoma 05/2019
1	Liver Failure 05/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 09/2017
1	De Lange Syndrome (Cornelia De Lange Syndrome) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2006
3	EnzymesIBA 06/2022 - 12/2013
3	Peptides (Polypeptides)IBA 12/2021 - 09/2017
3	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2019
2	Long Noncoding RNAIBA 05/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 03/2016
2	ChromatinIBA 01/2014 - 01/2013
1	Interleukin-22 (IL-22)IBA 08/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	lenvatinibIBA 06/2022
1	CreatinineIBA 06/2022
1	Amylases FDA Link 06/2022
1	sintilimabIBA 06/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2022
1	NucleosidesIBA 01/2022
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	hydroxide ionIBA 01/2021
1	ElectrolytesIBA 01/2021
1	Furosemide (Lasix)FDA LinkGeneric 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	NucleotidesIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	SodiumIBA 01/2021
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	25-hydroxyvitamin DIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 04/2020
1	Dietary Fiber FDA Link 02/2020
1	EndotoxinsIBA 02/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	SmokeIBA 01/2020
1	sodium bisulfide (NaHS)IBA 09/2019
1	Triglycerides (Triacylglycerol)IBA 09/2019
1	Hemoglobins (Hemoglobin)IBA 09/2019
1	Air Pollutants (Pollutants, Air)IBA 09/2019
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2019
1	Tiotropium Bromide (Spiriva)FDA Link 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	FilaminsIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 12/2017
1	VaccinesIBA 09/2017
1	CohesinsIBA 01/2017
1	Transcription Factor 4IBA 03/2016
1	Transcription Factors (Transcription Factor)IBA 03/2016
1	TCF Transcription FactorsIBA 01/2014
1	beta CateninIBA 01/2014

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 04/2021 - 01/2019
2	Immunotherapy 04/2021 - 09/2017
1	Art Therapy 01/2022
1	Therapeutics 04/2021
1	Intravenous Infusions 01/2021
1	Length of Stay 01/2021
1	Peritoneal Dialysis 01/2021
1	Critical Care (Surgical Intensive Care) 01/2020
1	Radiotherapy 02/2019
1	Renal Dialysis (Hemodialysis) 01/2019